Fatal leptospirosis presenting as musculoskeletal chest pain

Medical Journal of Australia

Volumn 180, Issue 1, 2004, Pages 29-31

  O'Leary, Fenton M ^a   Hunjan, Jaspal S ^a   Bradbury, Ross ^a   Thanakrishnan, Govindasamy ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; DEXAMETHASONE; ERYTHROMYCIN; INOTROPIC AGENT; METHYLPREDNISOLONE; METRONIDAZOLE; NORADRENALIN; PENICILLIN G; VASOPRESSIN;

ACUTE KIDNEY FAILURE; ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CARDIOMEGALY; CASE REPORT; DIARRHEA; ERYTHEMA; FATALITY; HEADACHE; HUMAN; HYPERKALEMIA; HYPOTENSION; IMMUNE COMPLEX DISEASE; INTERMITTENT POSITIVE PRESSURE VENTILATION; JAUNDICE; LEPTOSPIRA; LEPTOSPIRA GRIPPOTYPHOSA; LEPTOSPIROSIS; LOBAR PNEUMONIA; MALE; MULTIPLE ORGAN FAILURE; MUSCULOSKELETAL SYSTEM EXAMINATION; MYALGIA; MYOCARDITIS; OLIGURIA; RASH; RESPIRATORY FAILURE; RHABDOMYOLYSIS; TACHYCARDIA; THORAX DISEASE; THORAX PAIN; VOMITING;

EID: 0347629036     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb05770.x     Document Type: Article

References (8)

1. Communicable Diseases Australia. National notifiable disease surveillance system. Canberra: Department of Health and Ageing, March 2002. Available at: www1.health.gov.au/cda/Source/CDA-index.cfm (accessed Nov 2003).
2. Plank R, Dean D. Overview of the epidemiology, microbiology and pathogenesis of Leptospira spp. in humans. Microbes Infect 2000; 2; 1265-1276.
3. Smythe L, Dohnt M, Symonds M, et al. Review of Leptospirosis notifications in Queensland and Australia January 1998-June 1999. Commun Dis Intell 2000; 24: 153-157.
4. Centers for Disease Control and Prevention. Update: Leptospirosis and unexplained acute febrile illness among athletes participating in triathlons in Illinois and Wisconsin. JAMA 1998; 280: 1474-1475.
5. Dupont H, Dupont-Perdrizet D, Perie J, et al. Leptospirosis: Prognostic factors associated with mortality. Clin Infect Dis 1997; 25: 720-724.
6. Watt G, Padre L, Tuazon M, et al. Skeletal and cardiac muscle involvement in severe, late leptospirosis. J Infect Dis 1990; 162: 266-269.
7. Katz A, Ansdell V, Effler P, et al. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis 2001; 33: 1834-1841.
8. Guidugli F, Castro AA, Atallah AN. Antibiotics for leptospirosis (Cochrane review). In: The Cochrane Library, Issue 4, 2002. Oxford: Update Software.